After the remarkable success of the mRNA vaccines in protecting people against COVID-19, scientists are turning their attention next to another annual respiratory scourge: influenza. Both Moderna and Pfizer-BioNTech—makers of the first vaccines to earn U.S. Food and Drug Administration (FDA) …